Prostaglandin E1 in Outpatients With Intermittent Claudication

Summary

Investigate, under outpatient conditions, both the effect of 4 weeks of daily treatment with Prostaglandin E1 and that of 4 weeks of interval treatment (two infusions per week) on the pain-free walking distance in patients with Intermittent Claudication.

Timeline

Start

2001-04

Primary completion

2011-04

Completion

2011-04

Drugs

Indications